Position in CRMD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,329,865
-$2,817,907 QoQ
Shares Held
637,683
+3.8% QoQ
Ownership
0.813%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. CRMD ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,329,865 | 637,683 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,147,772 | 614,598 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,159,483 | 615,605 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $6,988,308 | 567,233 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,181,742 | 516,517 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,143,675 | 511,565 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,614,360 | 447,322 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,929,793 | 445,680 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,944,581 | 458,628 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,688,074 | 448,956 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,669,494 | 451,215 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,510,079 | 380,373 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $300,733 | 71,264 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $201,676 | 71,264 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $282,509 | 70,276 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,772,982 | 323,537 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,528,631 | 335,963 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,596,056 | 343,238 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,476,595 | 361,020 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,352,842 | 335,620 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $2,620,047 | 352,631 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,038,687 | 338,091 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,068,088 | 328,268 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $1,149,341 | 320,151 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||